03 Apr 2024
In this interview, Dr. Heidt explains the contribution of Leiden University Medical Center to the immunological part of ULISES.
In this interview, dr. Alfredo Minguela Puras, from the Biomedical Research Institute of Murcia, explains how his team is validating the ULISES therapy developed by the consortium through in vitro and in vivo (in humanized mice) assays.
Laura has beaten cancer but never been the same since. After being refused loans, mortgages, and adoption, she understood being one of many cancer survivors facing discrimination. And made of it a political commitment to their rights. Because “we are not half people, and still have all our dignity intact. And this is what I’m fighting for”
Being denied loans and adoptions, because of one’s medical records. The ‘return to life of many cancer survivors is a history of discrimination. European institutions and some member states are pushing for their “Right to be forgotten” but experts call for a deeper cultural change: “To overcome the stigma, our societies must acknowledge medicine’s progress: cancer is no longer a death sentence”